Abstract
Current Pharmacogenomics
Title: Subject Index to Volume 2
Volume: 3 Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Subject Index to Volume 2, Current Pharmacogenomics 2005; 3 (1) . https://dx.doi.org/10.2174/1570160053175009
DOI https://dx.doi.org/10.2174/1570160053175009 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
10
Related Articles
-
Estrogen Receptor Alpha: Impact of Ligands on Intracellular Shuttling and Turnover Rate in Breast Cancer Cells
Current Cancer Drug Targets Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics New Uses of Melatonin as a Drug; A Review
Current Medicinal Chemistry Somatic Mosaicism in Cases with Small Supernumerary Marker Chromosomes
Current Genomics The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
Current Pediatric Reviews Pluripotency and Targeted Reprogramming: Strategies, Disease Modeling and Drug Screening
Current Drug Delivery Gene Therapy for Neuroprotection and Neurorestoration (Part I)
Current Gene Therapy Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry Food Addiction and Neuroimaging
Current Pharmaceutical Design Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors
Current Gene Therapy Treatment of Circadian Rhythm Sleep–Wake Disorders
Current Neuropharmacology Human Imprinting Anomalies in Fetal and Childhood Growth Disorders: Clinical Implications and Molecular Mechanisms
Current Pharmaceutical Design Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells
Current Drug Targets Ion Channels and Epilepsy
Current Pharmaceutical Design Genome-Scale Technologies Foster Advances in Neurological and Behavioral Research
Current Psychiatry Reviews Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure
CNS & Neurological Disorders - Drug Targets Array-Comparative Genomic Hybridization Analysis of a Cohort of Saudi Patients with Epilepsy
CNS & Neurological Disorders - Drug Targets